Vins Bioproducts Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 20.00 Cr
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.33 Cr
- Satisfied Charges ₹ 4.66 Cr
- Revenue Growth 12.85%
- Profit Growth 17.86%
- Ebitda 11.71%
- Net Worth 15.67%
- Total Assets 16.41%
About Vins Bioproducts
Vins Bioproducts Limited (VBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 February 1997 and has a history of 27 years and 11 months. Its registered office is in Maheswaram, Telangana, India.
The Corporate was formerly known as Vins Bioproducts Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 20.00 Cr.
The company currently has active open charges totaling ₹22.33 Cr. The company has closed loans amounting to ₹4.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vins Bioproducts Limited India are Aayushi Jain as COMPANY SECRETARY and Khusboo Mundra as Cfo. Ravindrareddy Puli, Balkishan Badruka, Siddarth Daga, and Three other members serve as directors at the Company.
Company Details
-
Location
Maheswaram, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110TG1997PLC026437
-
Company No.
026437
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
17 Feb 1997
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Vins Bioproducts Limited offer?
Vins Bioproducts Limited offers a wide range of products and services, including Vaccines, Diphtheria Antitoxin, Common Disease Medicines, Injectable Products, Anti Snake Venom, Animal Medicines & Health Care, Veterinary Medicines, Tetanus Vaccine.
Who are the key members and board of directors at Vins Bioproducts?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aayushi Jain | Company Secretary | 01-Jul-2023 | Current |
Khusboo Mundra
|
CFO | 30-Mar-2015 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ravindrareddy Puli
|
Director | 31-May-2014 | Current |
|
Balkishan Badruka
|
Director | 30-Aug-2017 | Current |
|
Siddarth Daga
|
Whole-Time Director | 01-Apr-2013 | Current |
|
Sunaina Bihani
|
Director | 18-Jun-2021 | Current |
|
Shreedas Daga
|
Whole-Time Director | 30-Sep-2000 | Current |
|
Aruna Malani
|
Director | 31-May-2014 | Current |
Financial Performance of Vins Bioproducts.
Vins Bioproducts Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.85% increase. The company also saw a substantial improvement in profitability, with a 17.86% increase in profit. The company's net worth Soared by an impressive increase of 15.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vins Bioproducts?
In 2023, Vins Bioproducts had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Badruka Exim Pvt LtdBalkishan Badruka is a mutual person
-
Victoria Mri Centre Private LimitedSiddarth Daga and Sunaina Bihani are mutual person
-
Autofin LtdSiddarth Daga is a mutual person
-
Vins Lifesciences Private LimitedBalkishan Badruka and Siddarth Daga are mutual person
-
Care Fertility Solutions Private LimitedSunaina Bihani is a mutual person
-
Care Medical Solution Private Limited
Sunaina Bihani is a mutual person
Charges (Loans)
₹22.33 Cr
₹4.66 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 11.21 Cr
- Canara Bank : 10.00 Cr
- Others : 0.80 Cr
- Citi Bank N.A. : 0.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Sep 2021 | Others | ₹8.00 M | Open |
| 06 Jan 2021 | Hdfc Bank Limited | ₹1.21 Cr | Open |
| 17 Jul 2018 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 09 Jun 2014 | Citi Bank N.A. | ₹3.24 M | Open |
| 18 Aug 2004 | Canara Bank | ₹10.00 Cr | Open |
How Many Employees Work at Vins Bioproducts?
Unlock and access historical data on people associated with Vins Bioproducts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vins Bioproducts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vins Bioproducts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
